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relieved the subaortic stenosis. The "mitral" valve repair 
included a cleft closure and an annuloplasty. Today, 2 years 
later, there is no recurrence of the left ventricular outflow 
tract obstruction or of the left AV valve insufficiency. 
We would like to congratulate he authors on their large 
experience and we fully agree with their inferences. 
Nevertheless, we believe that it is important to distinguish 
between the two different aspects of the left superior 
leaflet detachment that could be performed before its 
augmentation. I  our opinion, detachment of the leaflet at 
the level of the septal crest is sometimes necessary to 
avoid subaortic stenosis after a primary repair of the 
anatomic type of AVSD that is likely to fail (i.e., partial 
and Rastelli type A AVSD). A further extension of the 
detachment in the aorta-left AV valve continuity might be 
appropriate only in an already present or recurrent left 
ventricular outflow tract obstruction because of its inher- 
ent risks for the left AV valve physiology. 
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Reply to the Editor: 
Mac6 and colleagues correctly infer that left atrioven- 
tricular (AV) valve augmentation in patients having atrio- 
ventricular septal defects (AVSDs) and subaortic stenosis 
may not be inconsequential. These are often redo opera- 
tions that limit the potential for use of autologous peri- 
cardium. Other materials may have less longevity. Stress 
at the suture line might also cause disruption. 
Detachment of the left superior leaflet, only from the 
septal crest, followed by leaflet augmentation effectively 
converts the anterior portion of the defect to a Rastelli 
type C lesion, l This is a lower risk procedure that has its 
place in the treatment of AVSDs and outlet narrowing. 
Patients with AVSDs having recurrent subaortic stenosis 
are a particular challenge. The outflow angle may be a 
marker for risk of subaortic stenosis. The outflow angle is 
defined by the angle created between the plane of the outlet 
septum and the plane of the closed left-sided anterior leaflet 
apparatus. 2 Normal hearts have an angle approaching 90 
degrees. The outflow angle in AVSDs varies but can be as 
small as zero degrees or approach normal. A narrow angle 
demonstrates anelongated outflow tract. This is a substrate 
for development of subaortic stenosis. 3 We hypothesize that 
an increase in the outflow angle may lessen the incidence of 
recurrent subaortic stenosis. The largest effective increase in 
the outflow angle is achieved by detaching the left superior 
bridging leaflet from the septal crest and extending the 
incision anteriorly and laterally to include excision of the 
increased aorta-left AV valve continuity. This area is then 
generously augmented with a patch. A subaortic myectomy is 
also performed. 
Because of the risk for the combined approach we 
perform standard subaortic resection and myectomy as a 
first line of treatment. Leaflet augmentation with subaor- 
tic myectomy or modified valve-sparing aortoventriculo- 
plasty 4is performed only in the event of recurrence and if 
the topography of the left ventricular outflow tract is 
significantly elongated and narrow. 
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Relation of cyclic guanosine monophosphate and 
cyclic adenosine monophosphate in reducing the 
toxic effects of protamine administration 
To the Editor: 
We read with great interest he article by Raikar and 
associates 1 regarding nitric oxide inhibition to relieve the 
adverse effects of protamine on blood pressure. They 
declared that hypotension caused by protamine adminis- 
tration can be blocked by nitrous oxide inhibition. We 
would like to add our experience to their information. 
Adverse effects of protamine administration on various 
organ systems have been known for a long time. These 
changes were attributed to the increased complement levels 
associated with an increase in thromboxane and leukotriene 
levels. These mediators may impair the function of organs 
such as the heart and lungs, although these changes are 
mostly clinically insignificant. We 2 documented that leuko- 
triene and thromboxane l vels increased after heparin rever- 
sal with protamine. These changes, which were associated 
with an increase in cyclic guanosine monophosphate 
(cGMP) levels and a reduction in cyclic adenosine mono- 
phosphate (cAMP) levels, adversely affected myocardial 
function. Monitoring cardiac output with a fast-response 
thermistor allowed us to calculate the ejection fraction 
changes in the right ventricle. After protamine administra- 
tion, while right ventricular end-diastolic volume became 
stable, right ventricular end-systolic volume increased signif- 
icantly, indicating the same degree of impairment in myo- 
cardial contractility. However, we did not observe any signif- 
icant change in pulmonary artery pressure. These pressure 
changes were associated with a temporary defect in myocar- 
dial oxidative metabolism, as indicated by the changes in 
myocardial oxygen consumption and myocardial lactate x- 
traction. Prostacyclin usage reduced the toxic mediator e- 
lease and improved myocardial function. After protamin e 
administration, we observed that protamine use decreased 
the cGMP level in the blood and increased the cAMP level 
in the blood. 2' 3 In light of this study, we hypothesized that a 
fall in cAMP level and a rise in cGMP level are responsible 
for the toxic manifestations of heparin reversal with prota- 
mine, similar to our observation during ischemic reperfu- 
sion. 4 On the basis of this information, we used aminophyl- 
line, a phosphodiesterase inhibitor, to increase the cAMP 
level and observed that aminophylline use reduced the toxic 
mediator elease and preserved myocardial function. 5 Fi- 
nally, adverse ffects of protamine on myocardial function 
can be controlled with agents that increase the cAMP levei. 
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Reply to the Editor: 
We appreciate the comments of Dr. Katircio~,lu and his 
colleagues. As noted in their letter, the adverse ffects of 
protamine may be mediated through a variety of mecha- 
nisms, including the complement system. In our study, we 
measured the serum level of cyclic guanosine monophos- 
phate (cGMP) and found no significant change with the 
administration of pr0tamine. Therefore we could not con- 
clude that a fall in the cGMP level correlated with the 
adverse ffects of protamine. This investigation focused on 
inhibition of the nitric oxide pathway, which decreased the 
systemic hypotension produced by protamine administra- 
tion. 
Attempts to attenuate the adverse ffects of protamine 
have met with variable degrees of success. There may be 
several effectors of the systemic effects of protamine, and 
these mechanisms might be expected to cause different 
clinical manifestations during protamine reversal of heparin. 
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Is left ventricular outflow tract obstruction really 
relieved on long-term follow-up? 
To the Editor." 
Luciani and associates I report good results in their 
article titled "One-Stage Repair of Interrupted Aortic 
Arch, Ventricular Septal Defect, and Subaortic Obstruc- 
tion in the Neonate: A Novel Approach." However, I am 
unsure about the long-term results. 
I treated a baby girl, not a neonate, who had a simple 
ventricular septal defect (VSD) associated with infundib- 
ular posterior malalignment, which caused only a 30 mm 
Hg pressure gradient through the left ventricular outflow 
tract (LVOT). Preoperative chocardiographic examina- 
tion showed that she had a large perimembranous VSD 
with a mild pressure gradient between the left ventricle 
and ascending aorta, which resulted from posterior eal- 
alignment of the infundibular septum to the LVOT. 
Cardiac catheterization showed that the right ventricular/ 
left ventricular pressure ratio was 0.9 and the pressure 
gradient through the LVOT was only 30 mm Hg. Cardiac 
angiography also showed that the infundibular septum 
significantly deviated to the LVOT and the ascending 
aorta was relatively small (6 mm). 
The patient was treated with catecholamines for cardiac 
